4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-17-012757
Options or other derivatives
- Pres. & Chief Executive Offic acquired 42,000 shares (grant or award)
From the SEC's structured data for this filing
Oruka Therapeutics, Inc. Filed Acc 0001209191-17-012757
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…